+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Acute Bacterial Skin and Skin Structure Infections Market by Type of Infection, Route of Administration, Distribution Channel, and By Region

  • PDF Icon

    Report

  • 200 Pages
  • March 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5941903
The global acute bacterial skin and skin structure infections market size was estimated to be USD 1.34 billion in 2023 and is expected to reach USD 2.31 billion by 2034 with a CAGR of 5.12% during the forecast period 2024-2034. Rising prevalence of acute bacterial skin and skin structure infections (ABSSSI), expanding access to healthcare, rapid technological advancements, growing awareness of ABSSSI, and collaborations and partnerships will drive market growth.

The market for acute bacterial skin and skin structure infections is expanding as a result of an increase in the frequency of bacterial skin infections, particularly those brought on by drug-resistant strains. A greater occurrence of these infections might be caused by variables such as immunocompromised states, skin injuries, and inadequate hygiene. For instance, in August 2023, Pfizer Inc. was granted FDA clearance for VEKLURY (omalizumab) injectable, which is intended to treat persistent hives that do not respond to traditional treatment methods. Enhancing general skin health may have an indirect benefit on managing ABSSSI.

By type of infection, the community-acquired ABSSSI segment accounted for the highest revenue-grossing segment in the global acute bacterial skin and skin structure infections market in 2023 owing to the increasing incidence of skin infections within community settings, rising awareness among healthcare professionals and the public about the significance of early diagnosis and treatment, and the development of effective antibiotics tailored for community-acquired pathogens. For instance, in September 2023, Sentieon Therapeutics and GlaxoSmithKline plc collaborated to explore new medicines for Gram-negative bacterial infections, which may have uses in the treatment of ABSSSI. Additionally, the hospital-acquired ABSSSI segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing prevalence of healthcare-associated infections, the rise in the number of hospitalized patients with compromised immune systems, and the heightened awareness regarding the importance of infection prevention and control measures within healthcare facilities.

By route of administration, the oral segment accounted for the highest revenue-grossing segment in the global acute bacterial skin and skin structure infections market in 2023 owing to the increasing preference for outpatient care, the convenience and patient compliance associated with oral antibiotic formulations, and the continuous development of orally administered antibiotics that offer effective and accessible treatment options for individuals with mild to moderate cases of ABSSSI. For instance, Novartis AG presented promising Phase 2a results in October 2023 for the use of the new antibiotic NIBRIO (OM1908) in the treatment of S. aureus infections, including ABSSSI. Additionally, the parenteral segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing severity of acute bacterial skin and skin structure infections, the need for rapid and targeted intervention in critical cases, and advancements in parenteral drug formulations that provide enhanced bioavailability and efficacy.

By distribution channel, the hospital pharmacies segment accounted for the highest revenue-grossing segment in the global acute bacterial skin and skin structure infections market in 2023 owing to the centralized role of hospitals in managing severe cases of ABSSSI, the increased prevalence of hospitalized patients requiring specialized treatment, and the convenient access to a diverse range of antibiotics within hospital pharmacy settings. For instance, in March 2023, Allergan published results at the American Academy of Dermatology meeting indicating the effectiveness of VIBATIV (telavancin) for the treatment of ABSSSI caused by S. aureus, particularly methicillin-resistant S. aureus (MRSA). AbbVie Inc. is purchasing Allergan plc. Additionally, the retail pharmacies segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend of outpatient care for managing mild to moderate cases of acute bacterial skin and skin structure infections (ABSSSI), the expanding role of community pharmacies in providing accessible healthcare services, and the growing emphasis on self-administration and convenience.

North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, high prevalence of acute bacterial skin and skin structure infections (ABSSSI), robust research and development activities, and a proactive approach towards adopting advanced medical treatments. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing incidence of acute bacterial skin and skin structure infections (ABSSSI), rising healthcare awareness, expanding access to medical services, and a growing emphasis on improving healthcare infrastructure. For instance, in November 2023, Sun Pharmaceutical Industries Ltd. introduced Cefdinir to the Indian market to treat a variety of bacterial infections, including ABSSSI.

This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Type of Infection, Route of Administration, and Distribution Channel
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players
  • 20% Free Customization Available to Meet Your Exact Requirement.

Segmentation: Acute Bacterial Skin and Skin Structure Infections Market Report 2023 - 2034

Acute Bacterial Skin and Skin Structure Infections Market Analysis & Forecast by Type of Infection 2023 - 2034 (Revenue USD Bn)

  • Hospital-acquired ABSSI
  • Community-acquired ABSSI

Acute Bacterial Skin and Skin Structure Infections Market Analysis & Forecast by Route of Administration 2023 - 2034 (Revenue USD Bn)

  • Oral
  • Parenteral
  • Topical

Acute Bacterial Skin and Skin Structure Infections Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Acute Bacterial Skin and Skin Structure Infections Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Acute Bacterial Skin and Skin Structure Infections Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Acute Bacterial Skin and Skin Structure Infections Market: Type of Infection Estimates & Trend Analysis
7.1. Type of Infection Segment Opportunity Analysis
7.2. Hospital-acquired ABSSI
7.2.1. Hospital-acquired ABSSI Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Community-acquired ABSSI
7.3.1. Community-acquired ABSSI Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Acute Bacterial Skin and Skin Structure Infections Market: Route of Administration Estimates & Trend Analysis
8.1. Route of Administration Segment Opportunity Analysis
8.2. Oral
8.2.1. Oral Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Parenteral
8.3.1. Parenteral Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Topical
8.4.1. Topical Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Acute Bacterial Skin and Skin Structure Infections Market: Distribution Channel Estimates & Trend Analysis
9.1. Distribution Channel Segment Opportunity Analysis
9.2. Hospital Pharmacies
9.2.1. Hospital Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Retail Pharmacies
9.3.1. Retail Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Online Pharmacies
9.4.1. Online Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Acute Bacterial Skin and Skin Structure Infections Market
11.1. North America Acute Bacterial Skin and Skin Structure Infections Market
11.1.1. North America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
11.1.4. North America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
11.1.5. North America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Acute Bacterial Skin and Skin Structure Infections Market
11.2.1. U.S. Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Acute Bacterial Skin and Skin Structure Infections Market
11.3.1. Canada Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12. Europe Global Acute Bacterial Skin and Skin Structure Infections Market
12.1. Europe Global Acute Bacterial Skin and Skin Structure Infections Market
12.1.1. Europe Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Acute Bacterial Skin and Skin Structure Infections Market
12.2.1. Germany Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. UK Global Acute Bacterial Skin and Skin Structure Infections Market
12.3.1. UK Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
12.3.3. UK Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.3.4. UK Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.4. France Global Acute Bacterial Skin and Skin Structure Infections Market
12.4.1. France Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
12.4.3. France Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.4.4. France Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Acute Bacterial Skin and Skin Structure Infections Market
12.5.1. Spain Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Acute Bacterial Skin and Skin Structure Infections Market
12.6.1. Italy Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Acute Bacterial Skin and Skin Structure Infections Market
12.7.1. Rest of Europe Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Acute Bacterial Skin and Skin Structure Infections Market
13.1. Asia Pacific Global Acute Bacterial Skin and Skin Structure Infections Market
13.1.1. Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Acute Bacterial Skin and Skin Structure Infections Market
13.2.1. Japan Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. China Global Acute Bacterial Skin and Skin Structure Infections Market
13.3.1. China Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
13.3.3. China Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.3.4. China Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. India Global Acute Bacterial Skin and Skin Structure Infections Market
13.4.1. India Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
13.4.3. India Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.4.4. India Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Acute Bacterial Skin and Skin Structure Infections Market
13.5.1. South Korea Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Acute Bacterial Skin and Skin Structure Infections Market
13.6.1. Australia Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Acute Bacterial Skin and Skin Structure Infections Market
13.7.1. Rest of Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. Latin America Global Acute Bacterial Skin and Skin Structure Infections Market
14.1. Latin America Global Acute Bacterial Skin and Skin Structure Infections Market
14.1.1. Latin America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Acute Bacterial Skin and Skin Structure Infections Market
14.2.1. Brazil Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Acute Bacterial Skin and Skin Structure Infections Market
14.3.1. Mexico Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Acute Bacterial Skin and Skin Structure Infections Market
14.4.1. Argentina Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Acute Bacterial Skin and Skin Structure Infections Market
14.5.1. Rest of Latin America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. MEA Global Acute Bacterial Skin and Skin Structure Infections Market
15.1. MEA Global Acute Bacterial Skin and Skin Structure Infections Market
15.1.1. MEA Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Acute Bacterial Skin and Skin Structure Infections Market
15.2.1. GCC Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Acute Bacterial Skin and Skin Structure Infections Market
15.3.1. South Africa Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Acute Bacterial Skin and Skin Structure Infections Market
15.4.1. Rest of MEA Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Type of Infection, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Acute Bacterial Skin and Skin Structure Infections Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Pfizer Inc.
17.2. Merck & Co., Inc.
17.3. GlaxoSmithKline plc
17.4. Novartis AG
17.5. Allergan plc (acquired by AbbVie Inc.)
17.6. Johnson & Johnson
17.7. Bristol Myers Squibb Company
17.8. Cubist Pharmaceuticals (acquired by Merck & Co.)
17.9. Teva Pharmaceutical Industries Ltd.
17.10. Melinta Therapeutics, Inc.
17.11. F. Hoffmann-La Roche Ltd.
17.12. Cempra, Inc. (acquired by Melinta Therapeutics)
17.13. Sun Pharmaceutical Industries Ltd.
17.14. Actavis, Inc. (now part of Teva Pharmaceutical Industries Ltd.)
17.15. Daiichi Sankyo Company, Limited
18. Conclusion19. Recommendations

Companies Mentioned

  • Pfizer Inc.
  • Merck & Co. Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Allergan plc (acquired by AbbVie Inc.)
  • Johnson & Johnson
  • Bristol Myers Squibb Company
  • Cubist Pharmaceuticals (acquired by Merck & Co.)
  • Teva Pharmaceutical Industries Ltd.
  • Melinta Therapeutics Inc.
  • F. Hoffmann-La Roche Ltd.
  • Cempra Inc. (acquired by Melinta Therapeutics)
  • Sun Pharmaceutical Industries Ltd.
  • Actavis Inc. (now part of Teva Pharmaceutical Industries Ltd.)
  • Daiichi Sankyo Company Limited.

Table Information